LBCA’s Scientific Advisory Board (SAB) members have co-authored 18 ILC specific studies so far this year. See the links below to read more about our SAB members’ eight most recent publications. To view all 2026 SAB members’ publications, visit the SAB Member ILC Research page on our website.
SAB Member Dr. Christos Sotiriou co-authored:
- World Health Organization classification of tumours of the breast 6th edition 2026, in Histopathology, April 2026.
SAB Member Dr. Daniel Stover co-authored:
- Multidimensional Cellular Micro-Compartments to Model Invasive Lobular Carcinoma Dormancy, in Advanced Healthcare Materials, May 2026.
SAB Member Dr. Fresia Pareja co-authored:
- Invasive Lobular Carcinoma: Clinicopathologic and Biological Insights, in Annales de Pathologie, July 2026.
SAB Chair Dr. Jason Mouabbi co-authored:
- Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma, in Annals of Surgical Oncology, July 2026.
SAB Chair Dr. Jason Mouabbi and SAB Member Dr. Megan Kruse co-authored a conference abstract:
- 119 Progression-Free Survival (PFS) and Overall Survival (OS) Results From the Phase 3 MONALEESA-3 Trial of Postmenopausal Patients With Hormone Receptor–Positive (HR+)/Human Epidermal Growth Factor Receptor 2– Negative (HER2−) Advanced Breast Cancer (ABC) Treated With Ribociclib (RIB) + Fulvestrant (FUL): A Subgroup Analysis of Patients With Invasive Lobular Carcinoma (ILC), in the Miami Breast Cancer Conference Abstracts Supplement, 2026.
SAB Member Dr. Megan Kruse co-authored:
- Invasive lobular carcinoma: Shining a light on the second most prevalent type of breast cancer, in The Nurse Practitioner, June 2026.
SAB Member Dr. Patrick Derksen co-authored:
- Invasive lobular breast cancer in young patients without adjuvant systemic treatment: 15-year survival outcomes, in Breast Cancer Research and Treatment, August 2026.
SAB Member Dr. Rita Mukhtar co-authored:
- Omission of Axillary Surgery in Patients with Invasive Lobular Carcinoma of the Breast: Rates of Nodal Involvement in Clinically Node Negative Patients and Impact on Recurrence in a Single Institution Analysis, in Annals of Surgical Oncology, July 2026.